Status:
TERMINATED
Clinician Assessment of Patient Dyspnea
Lead Sponsor:
Rush University Medical Center
Conditions:
Dyspnea
Eligibility:
All Genders
18+ years
Brief Summary
Background: Dyspnea, like pain, is subjective and challenging to assess despite the large number of patients that report shortness of breath. Several studies have shown that physicians and nurses inac...
Detailed Description
According to the American Thoracic Society (ATS), the term dyspnea characterizes the subjective experience of breathing discomfort of patients. Dyspnea, like pain, is subjective. Currently, there is n...
Eligibility Criteria
Inclusion
- Adult subjects 18 years and older,
- Admitted to RUMC
- Non-intubated,
- Admitted with a diagnosis of heart failure (HF), chronic obstructive pulmonary disease (COPD), asthma, pneumonia, a generic diagnosis of shortness of breath, or requiring supplemental oxygen support.
Exclusion
- Less than 18 years old,
- Non-English-speaking,
- Subjects unable to answer questions about dyspnea for any reason.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 3 2024
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT05319379
Start Date
April 1 2022
End Date
January 3 2024
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60187